GB2588505B - Preparation of psilocybin - Google Patents
Preparation of psilocybin Download PDFInfo
- Publication number
- GB2588505B GB2588505B GB2012911.0A GB202012911A GB2588505B GB 2588505 B GB2588505 B GB 2588505B GB 202012911 A GB202012911 A GB 202012911A GB 2588505 B GB2588505 B GB 2588505B
- Authority
- GB
- United Kingdom
- Prior art keywords
- psilocybin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QVDSEJDULKLHCG-UHFFFAOYSA-N Psilocybine Natural products C1=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CNC2=C1 QVDSEJDULKLHCG-UHFFFAOYSA-N 0.000 title 1
- QKTAAWLCLHMUTJ-UHFFFAOYSA-N psilocybin Chemical compound C1C=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CN=C21 QKTAAWLCLHMUTJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1716505.1A GB2571696B (en) | 2017-10-09 | 2017-10-09 | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| GB1810588.2A GB2572023C2 (en) | 2017-10-09 | 2018-06-28 | Crystaline psilocybin polymorph A, a formulation and uses thereof together with a method of preparation |
| GB1816438.4A GB2576059B (en) | 2017-10-09 | 2018-10-09 | A pharmaceutical formulation comprising psilocybin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB202012911D0 GB202012911D0 (en) | 2020-09-30 |
| GB2588505A GB2588505A (en) | 2021-04-28 |
| GB2588505B true GB2588505B (en) | 2022-08-03 |
Family
ID=72615505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2012911.0A Active GB2588505B (en) | 2017-10-09 | 2018-10-09 | Preparation of psilocybin |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2588505B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022553135A1 (en) | 2020-05-19 | 2024-03-04 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| EP4155306A1 (en) | 2021-01-15 | 2023-03-29 | Beckley Psytech Limited | Neuroactive ergoline analogue |
| WO2023105222A1 (en) * | 2021-12-07 | 2023-06-15 | Beckley Psytech Limited | Pharmaceutical composition |
| EP4486448A1 (en) | 2022-03-04 | 2025-01-08 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| US12264131B2 (en) | 2022-08-19 | 2025-04-01 | Beckley Psytech Limited | Pharmaceutically acceptable salts and compositions thereof |
| US12246005B2 (en) | 2023-06-13 | 2025-03-11 | Beckley Psytech Limited | 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations |
| GB202313750D0 (en) * | 2023-09-08 | 2023-10-25 | Psyence Group Inc | A process for obtaining a purified psychoactive alkaloid |
-
2018
- 2018-10-09 GB GB2012911.0A patent/GB2588505B/en active Active
Non-Patent Citations (2)
| Title |
|---|
| Journal of Natural Products, Vol. 66(6), 2003, (Shirota, Osamu et al), pages 885-887, ISSN: 0163-3864. * |
| Synthesis Vol. 6, 1999, (Nichols, David E. et al), pages 935-938, ISSN: 0039-7881. * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2588505A (en) | 2021-04-28 |
| GB202012911D0 (en) | 2020-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272888B1 (en) | Novel uses of piperidinyl-indole derivatives | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| GB2588505B (en) | Preparation of psilocybin | |
| SG10202111790YA (en) | Synthesis of omecamtiv mecarbil | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| SMT202100551T1 (en) | Derivatives of sobetirome | |
| IL274627A (en) | Solid state form of valbenazine | |
| IL272697A (en) | Polymorphic form of tg02 | |
| PT3661491T (en) | Use of 3-methylmethcathinone | |
| IL276592A (en) | Derivatives of sobetirome | |
| PT3334734T (en) | Form c of avibactam sodium | |
| IL272857A (en) | Formulations of copanlisib | |
| EP3384921A4 (en) | New use of thiopeptin | |
| IL293192A (en) | Methods of preparing indolinobenzodiazepine derivatives | |
| GB201609314D0 (en) | Methods of forming compounds | |
| IL270961A (en) | Crystalline form of n-butyldeoxygalactonojirimycin | |
| HUE050745T2 (en) | Use of levelling compound | |
| IL248139B (en) | Preparation of micro-electrodes | |
| PT3678644T (en) | Formulations of copanlisib | |
| IL249130A0 (en) | Preparation of piperidine-4-carbothioamide | |
| SG11202105136WA (en) | Application of chidamide | |
| HK40051691A (en) | Preparation of psilocybin | |
| HK40051691B (en) | Preparation of psilocybin | |
| PT3901141T (en) | Novel form of isoquinolinesulfonamide | |
| GB201721386D0 (en) | Chrondogy of time-wave |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40051691 Country of ref document: HK |